Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was upgraded by JPMorgan Chase & Co. from a “neutral” rating to an ...

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has earned a consensus rating of “Moderate Buy” from the twenty ...

Cantor Fitzgerald said that while the firm “congratulates” Alnylam Pharmaceuticals (ALNY) on last week’s Amvuttra approval, with the stock ...

Combining statins with another drug, ezetimibe, significantly reduces the risk of death in patients with clogged arteries, ...

One diet came out a clear winner in a 30-year study involving more than 105,000 men and women and eight diets, researchers ...

Craig-Hallum analyst Matt Hewitt says the firm expects patient investors to be awarded following news that Codexis (CDXS) has signed their ...

The Food and Drug Administration (FDA) has approved Amvuttra ® (vutrisiran) for the treatment of the cardiomyopathy of ...

The partnership’s primary goal is to integrate NVIDIA's AI technology across Cognizant’s enterprise technology stack.

Shares of Charles River Laboratories International Inc. slipped 3.37% to $161.35 Tuesday, on what proved to be an all-around ...

The United States market has shown a positive trend, rising 1.8% over the last week and 10% over the past year, with earnings projected to grow by 14% annually. In this environment, identifying high ...

Over the last 7 days, the United States market has risen by 1.8%, contributing to a 10% increase over the past year, with earnings projected to grow by 14% annually in the coming years. In this ...

Maravai LifeSciences Holdings Inc (MRVI) is expected to report $-0.07 for 4Q. McCormick & Co Inc (MKC) is expected to report $0.64 for 1Q. Movado Group Inc (MOV) is expected to report $0.39 for 4Q.